Do Wall Street Analysts Like Teradyne Stock?
The article says 16 analysts cover Teradyne, with a consensus “Strong Buy” based on 12 “Strong Buy,” one “Moderate Buy,” and three “Hold” ratings. It notes JPMorgan’s Joseph Cardoso raised Teradyne’s price target to $465 from $450 on July 30, 2026, keeping an “Overweight” rating. The mean target is $447.86 and the Street-high is $550.
How this was made
The 30-second read
Why it matters
This is primarily sentiment and valuation framing from sell-side research, not a new operational or financial datapoint from Teradyne.
Market read
Traders may treat the update as a mild positive for positioning, but it lacks a fresh fundamental catalyst.
What to watch
The article does not state whether Teradyne’s latest results or backlog changed, so traders should avoid extrapolating from targets alone.
Background
The piece summarizes analyst coverage and highlights a JPMorgan price-target increase for Teradyne.
Ticker impact
JPMorgan raised Teradyne’s price target to $465 from $450 and kept an Overweight rating, signaling continued bullish expectations.
Near-term bias modestly positive, with limited follow-through unless additional company-specific catalysts emerge.
The only new, concrete fact is the JPMorgan target increase; there is no earnings, guidance, contract, or operational update in the text.
Market effects
Supports sentiment for industrial automation/semicap equipment names, but no sector-wide data or cross-company catalyst is provided.
No direct regional linkage beyond general Wall Street sentiment.
No global macro or international event is tied to the analyst changes.
Counterpoint
Analyst target hikes can lag or fail to translate into fundamentals; without new company disclosures, the move may be incremental.
Key entities
- companyTeradyne
Subject of the article, with a highlighted JPMorgan price-target increase and unchanged Overweight rating.
- analyst_firmJPMorgan
Raised Teradyne’s price target to $465 from $450 while maintaining Overweight.
